1. Home
  2. HROW vs MLKN Comparison

HROW vs MLKN Comparison

Compare HROW & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

N/A

Current Price

$30.61

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

N/A

Current Price

$20.15

Market Cap

1.4B

ML Signal

N/A

Company Overview

Basic Information
Metric
HROW
MLKN
Founded
1998
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
HROW
MLKN
Price
$30.61
$20.15
Analyst Decision
Strong Buy
Buy
Analyst Count
9
2
Target Price
★ $65.00
N/A
AVG Volume (30 Days)
486.5K
★ 585.8K
Earning Date
11-09-2026
09-22-2026
Dividend Yield
N/A
★ 3.81%
EPS Growth
71.43
★ 344.44
EPS
N/A
★ 0.38
Revenue
N/A
★ $3,841,700,000.00
Revenue This Year
$28.81
$2.23
Revenue Next Year
$53.97
$4.25
P/E Ratio
★ N/A
$15.24
Revenue Growth
N/A
★ 4.68
52 Week Low
$28.54
$13.77
52 Week High
$54.98
$24.71

Technical Indicators

Market Signals
Indicator
HROW
MLKN
Relative Strength Index (RSI) 27.10 29.85
Support Level $28.54 $19.12
Resistance Level $35.43 $19.57
Average True Range (ATR) 1.25 0.79
MACD -0.21 -0.10
Stochastic Oscillator 11.48 0.00

Price Performance

Historical Comparison
HROW
MLKN

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: